Theravectys S.A.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer (NCT06319963) | Theravectys S.A. | 2024-08-08 |
Track Theravectys S.A. automatically
Every clearance here is in the API, with alerts when new ones post.